NCT03227380

Brief Summary

The objective of this study is to determine whether stapling adversely affects the pulmonary parenchyma and the vascularisation of the adjacent segments. The aim of our work is to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy, 3 or 6 months post-surgery. the investigator will assess venous drainage and the arterial vascularisation of the remaining segments, possible modifications of the adjacent parenchyma and whether there is a defect of pleuro-pulmonary adhesion (residual pneumothorax).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 24, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2018

Completed
Last Updated

July 24, 2017

Status Verified

July 1, 2017

Enrollment Period

11 months

First QC Date

June 19, 2017

Last Update Submit

July 21, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • The measure of the remaining segments after stapling the intersegmental plane by injected CT scan

    The aim of investigators work is to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy, from 3 to 6 months post-surgery. The investigators will assess venous drainage and the arterial vascularisation of the remaining segments, possible modifications of the adjacent parenchyma and whether there is a defect of pleuro-pulmonary adhesion (residual pneumothorax). The radiological evaluation criteria will be: * Presence and quantification of a defect in pulmonary expansion (residual pneumothorax) * Abnormal venous and arterial vascularisation of the remaining segments * Defect of the pulmonary parenchyma in contact with the staples line (atelectasis, vascularisation defect)

    3 or 6 months after surgery

Study Arms (1)

radiological evaluation

OTHER

to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy

Other: thoracic densitometry with contrast

Interventions

injected CT scan at 3 or 6 months after segmentectomy VATS

radiological evaluation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Enrolment in the study will be offered to all patients having undergone a programmed scheduled video-assisted thoracoscopic segmentectomy, whatever the aetiology.
  • Men or women aged 18 years or greater
  • Absence of severe hepatic insufficiency
  • signed and dated informed consent
  • candidate for segmentectomy
  • Registration in a national healthcare system.
  • Women of child-bearing age using effective oral or barrier contraception

You may not qualify if:

  • Proven intolerance to iodinated contrast agents
  • Know allergy or non-controlled asthma - pregnancy
  • Severe hepatic insufficiency (creatinine clearance \< 30ml/min, by Cockroft's method)
  • Pregnant or breastfeeding women
  • Patients under trusteeship or curators
  • Diabetic patients or patients receiving oral antidiabetic medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institut Mutualiste montsouris

Paris, 75014, France

RECRUITING

Institut mutualiste montsouris

Paris, 75014, France

RECRUITING

MeSH Terms

Interventions

Contrast Media

Intervention Hierarchy (Ancestors)

Diagnostic Uses of ChemicalsPharmacologic ActionsChemical Actions and UsesSpecialty Uses of Chemicals

Central Study Contacts

Agathe SEGUIN-GIVELET, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: patients undergo anatomic segmentectomy by video-assisted thoracoscopic surgery (VATS)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2017

First Posted

July 24, 2017

Study Start

March 31, 2017

Primary Completion

February 20, 2018

Study Completion

August 30, 2018

Last Updated

July 24, 2017

Record last verified: 2017-07

Locations